Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001398344-25-009434
Filing Date
2025-05-14
Accepted
2025-05-14 17:13:45
Documents
3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 9475
2 fp0093537-1_991.htm EX-99.1 5967
3 fp0093537-1_992.htm EX-99.2 5664
  Complete submission text file 0001398344-25-009434.txt   22696
Mailing Address 712 FIFTH AVE 45TH FL NEW YORK NY 10019
Business Address
FELDMAN STUART (Filed by) CIK: 0001237237 (see all company filings)

Type: SCHEDULE 13G

Mailing Address 10 EARLSFORT TERRACE DUBLIN 2 L2 D02 T380
Business Address 10 EARLSFORT TERRACE DUBLIN 2 L2 D02 T380 353 1 905 8020
Mural Oncology plc (Subject) CIK: 0001971543 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-94252 | Film No.: 25947058
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)